Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The aim of the study is to compare the effect of ciclesonide on quality of life, pulmonary function and time to first exacerbation in patients with moderate persistent asthma. Ciclesonide will be administered once daily in the evening at two dose levels. The study duration consists of a baseline period (2 weeks) and a treatment period (8 weeks).
Epistemonikos ID: fd64a23e23785fe3b4c35089600ca8131a6f9b37
First added on: May 04, 2024